The BACH1/Nrf2 Axis in Brain in Down Syndrome and Transition to Alzheimer Disease-Like Neuropathology and Dementia.
Alzheimer disease
BACH1
Down syndrome
Nrf2
oxidative stress
Journal
Antioxidants (Basel, Switzerland)
ISSN: 2076-3921
Titre abrégé: Antioxidants (Basel)
Pays: Switzerland
ID NLM: 101668981
Informations de publication
Date de publication:
21 Aug 2020
21 Aug 2020
Historique:
received:
29
07
2020
revised:
14
08
2020
accepted:
17
08
2020
entrez:
26
8
2020
pubmed:
26
8
2020
medline:
26
8
2020
Statut:
epublish
Résumé
Down syndrome (DS) is the most common genetic cause of intellectual disability that is associated with an increased risk to develop early-onset Alzheimer-like dementia (AD). The brain neuropathological features include alteration of redox homeostasis, mitochondrial deficits, inflammation, accumulation of both amyloid beta-peptide oligomers and senile plaques, as well as aggregated hyperphosphorylated tau protein-containing neurofibrillary tangles, among others. It is worth mentioning that some of the triplicated genes encoded are likely to cause increased oxidative stress (OS) conditions that are also associated with reduced cellular responses. Published studies from our laboratories propose that increased oxidative damage occurs early in life in DS population and contributes to age-dependent neurodegeneration. This is the result of damaged, oxidized proteins that belong to degradative systems, antioxidant defense system, neuronal trafficking. and energy metabolism. This review focuses on a key element that regulates redox homeostasis, the transcription factor Nrf2, which is negatively regulated by BACH1, encoded on chromosome 21. The role of the Nrf2/BACH1 axis in DS is under investigation, and the effects of triplicated BACH1 on the transcriptional regulation of Nrf2 are still unknown. In this review, we discuss the physiological relevance of BACH1/Nrf2 signaling in the brain and how the dysfunction of this system affects the redox homeostasis in DS neurons and how this axis may contribute to the transition of DS into DS with AD neuropathology and dementia. Further, some of the evidence collected in AD regarding the potential contribution of BACH1 to neurodegeneration in DS are also discussed.
Identifiants
pubmed: 32839417
pii: antiox9090779
doi: 10.3390/antiox9090779
pmc: PMC7554729
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : NIH HHS
ID : AG055596-01A1
Pays : United States
Références
Free Radic Biol Med. 2008 Jun 15;44(12):2051-7
pubmed: 18423383
Free Radic Biol Med. 2018 Jan;114:84-93
pubmed: 28705658
Free Radic Biol Med. 2017 Oct;111:262-269
pubmed: 27838436
Proteomics Clin Appl. 2014 Feb;8(1-2):73-85
pubmed: 24259517
Biochem J. 2014 Oct 15;463(2):177-89
pubmed: 25242166
EMBO J. 2001 Jun 1;20(11):2835-43
pubmed: 11387216
J Biol Chem. 2011 Jul 1;286(26):23521-32
pubmed: 21555518
J Cell Biol. 2003 Apr 14;161(1):41-54
pubmed: 12695498
Biochem Biophys Res Commun. 2018 Dec 9;507(1-4):114-121
pubmed: 30449595
Sci Rep. 2017 Aug 8;7(1):7568
pubmed: 28790431
Curr Gerontol Geriatr Res. 2012;2012:724904
pubmed: 22203843
Eur J Neurosci. 2004 May;19(10):2711-9
pubmed: 15147305
Neurosci Lett. 2008 Aug 1;440(2):160-5
pubmed: 18555605
Ann Neurol. 2000 Nov;48(5):795-8
pubmed: 11079545
Proc Natl Acad Sci U S A. 2004 Feb 10;101(6):1461-6
pubmed: 14747657
Ageing Res Rev. 2019 Sep;54:100942
pubmed: 31415806
Oxid Med Cell Longev. 2018 Oct 2;2018:1347969
pubmed: 30370001
Neuroscience. 1994 Nov;63(1):223-31
pubmed: 7534881
Biochem J. 2011 May 1;435(3):679-88
pubmed: 21338338
Oxid Med Cell Longev. 2016;2016:2756068
pubmed: 26881020
J Neural Transm Suppl. 2001;(61):193-201
pubmed: 11771743
J Neural Transm Suppl. 2003;(67):39-49
pubmed: 15068237
Curr Alzheimer Res. 2016;13(1):18-29
pubmed: 26651341
Biochim Biophys Acta. 2015 Jul;1852(7):1428-41
pubmed: 25857617
Biochim Biophys Acta. 2013 Aug;1832(8):1249-59
pubmed: 23603808
Nature. 1995 Dec 21-28;378(6559):776-9
pubmed: 8524410
Free Radic Biol Med. 2014 Jun;71:270-80
pubmed: 24675226
Biochem J. 2008 Aug 1;413(3):405-16
pubmed: 18412543
Cell Metab. 2013 Jan 8;17(1):132-40
pubmed: 23312288
Neurobiol Dis. 2014 Feb;62:144-59
pubmed: 24095978
BMC Genomics. 2007 Aug 07;8:268
pubmed: 17683628
Annu Rev Pharmacol Toxicol. 1997;37:517-54
pubmed: 9131263
Prog Brain Res. 2012;197:101-21
pubmed: 22541290
J Neural Transm Suppl. 2003;(67):193-205
pubmed: 15068251
J Clin Med. 2020 May 21;9(5):
pubmed: 32455831
Acta Neuropathol. 2009 Jul;118(1):131-50
pubmed: 19288120
Free Radic Biol Med. 2018 Jan;114:69-83
pubmed: 28838841
Antioxid Redox Signal. 2012 Dec 1;17(11):1610-55
pubmed: 22115501
Brain Res. 1996 Mar 25;713(1-2):211-22
pubmed: 8724993
Hum Mol Genet. 2016 May 1;25(9):1714-27
pubmed: 26911678
Cell Mol Biol (Noisy-le-grand). 2000 May;46(3):573-85
pubmed: 10872744
Physiol Rev. 2014 Jul;94(3):909-50
pubmed: 24987008
Adv Exp Med Biol. 2019;1184:407-416
pubmed: 32096053
J Dev Behav Pediatr. 2001 Feb;22(1):40-59
pubmed: 11265922
Antioxid Redox Signal. 2013 Sep 10;19(8):823-35
pubmed: 23249141
Free Radic Biol Med. 2015 Nov;88(Pt B):314-336
pubmed: 26066302
Antioxid Redox Signal. 2010 Dec 1;13(11):1665-78
pubmed: 20446768
J Alzheimers Dis. 2015;44(4):1107-20
pubmed: 25391381
Biochim Biophys Acta. 2012 Feb;1822(2):130-8
pubmed: 22009041
FASEB J. 2017 Sep;31(9):3999-4010
pubmed: 28536120
EMBO J. 2002 Oct 1;21(19):5216-24
pubmed: 12356737
Antioxid Redox Signal. 2017 Mar 1;26(7):280-298
pubmed: 27627691
J Alzheimers Dis. 2018;62(3):1345-1367
pubmed: 29562527
Biochem J. 2009 Jan 1;417(1):1-13
pubmed: 19061483
Antioxid Redox Signal. 2004 Oct;6(5):878-87
pubmed: 15345148
Am J Med. 1991 Sep 30;91(3C):14S-22S
pubmed: 1928205
Nat Rev Neurosci. 2019 Mar;20(3):148-160
pubmed: 30737462
Biochim Biophys Acta. 2011 Nov;1812(11):1359-70
pubmed: 21871956
Ann Diagn Pathol. 2018 Jun;34:103-109
pubmed: 29661714
Biogerontology. 2006 Aug;7(4):211-20
pubmed: 16612664
J Neuropathol Exp Neurol. 2007 Jan;66(1):75-85
pubmed: 17204939
Neurosci Biobehav Rev. 2014 Oct;46 Pt 2:202-17
pubmed: 24548784
Proc Natl Acad Sci U S A. 2001 Sep 25;98(20):10996-1002
pubmed: 11572959
Neurobiol Aging. 2007 May;28(5):648-76
pubmed: 16624449
J Neurotrauma. 2009 Jan;26(1):31-9
pubmed: 19119918
J Neurochem. 2019 Nov;151(4):459-487
pubmed: 30216447
Brain Res Dev Brain Res. 1998 Feb 10;105(2):181-94
pubmed: 9541737
Mol Neurobiol. 2017 Dec;54(10):7979-7993
pubmed: 27878758
Trends Pharmacol Sci. 2009 Mar;30(3):129-37
pubmed: 19217170
Mol Cell Biol. 1996 Nov;16(11):6083-95
pubmed: 8887638
Mol Cell Neurosci. 2008 Nov;39(3):302-13
pubmed: 18706502
Neurosci Lett. 2000 Mar 17;282(1-2):57-60
pubmed: 10713395
J Biol Chem. 2006 Aug 25;281(34):24756-68
pubmed: 16790436
J Physiol. 2003 Oct 15;552(Pt 2):335-44
pubmed: 14561818
Neurobiol Dis. 2015 Dec;84:69-77
pubmed: 25731746
Curr Opin Neurol. 2004 Apr;17(2):95-100
pubmed: 15021233
J Neurol Sci. 2007 Mar 15;254(1-2):22-7
pubmed: 17275850
Oxid Med Cell Longev. 2019 May 9;2019:2105607
pubmed: 31210837
J Biol Chem. 2010 Jan 1;285(1):153-62
pubmed: 19897490
J Biol Chem. 2003 Dec 5;278(49):49246-53
pubmed: 14504288
Neurobiol Dis. 2009 Mar;33(3):369-78
pubmed: 19101630
EMBO J. 2004 Jul 7;23(13):2544-53
pubmed: 15175654
Free Radic Biol Med. 2002 Sep 1;33(5):620-6
pubmed: 12208348
J Biol Chem. 2005 Apr 29;280(17):16891-900
pubmed: 15734732
Prog Neurobiol. 2019 Jan;172:40-70
pubmed: 30009872
Cell. 2004 Jan 23;116(2):281-97
pubmed: 14744438
J Neuropathol Exp Neurol. 2001 Aug;60(8):759-67
pubmed: 11487050
Behav Brain Res. 2014 Sep 1;271:140-6
pubmed: 24837743